The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-3-[3-hydroxy-5-(2-methyl-2H-tetrazol-5-yl)-isoxazol-4-yl]-propionic acid ID: ALA94859
PubChem CID: 3481675
Max Phase: Preclinical
Molecular Formula: C8H10N6O4
Molecular Weight: 254.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cn1nnc(-c2onc(O)c2CC(N)C(=O)O)n1
Standard InChI: InChI=1S/C8H10N6O4/c1-14-11-6(10-13-14)5-3(7(15)12-18-5)2-4(9)8(16)17/h4H,2,9H2,1H3,(H,12,15)(H,16,17)
Standard InChI Key: YXLQKZHKWIKJKC-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
3.9917 -6.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5792 -5.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8042 -4.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1167 -7.1542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1750 -6.2042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7917 -6.9375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2667 -6.2042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3792 -7.5250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9167 -5.6917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6292 -4.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3875 -4.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1500 -3.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5625 -4.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5667 -2.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0375 -4.1917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9750 -4.8167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3167 -3.5125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2417 -8.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 1 2 0
5 1 1 0
6 5 2 0
7 2 1 0
8 4 1 0
9 7 1 0
10 3 1 0
11 3 1 0
12 13 1 0
13 11 1 0
14 12 2 0
15 10 1 0
16 13 1 0
17 12 1 0
18 8 1 0
8 6 1 0
10 9 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 254.21Molecular Weight (Monoisotopic): 254.0764AlogP: -1.47#Rotatable Bonds: 4Polar Surface Area: 153.18Molecular Species: ZWITTERIONHBA: 9HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 1.81CX Basic pKa: 8.80CX LogP: -2.52CX LogD: -4.25Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.59Np Likeness Score: -0.74
References 1. Bang-Andersen B, Lenz SM, Skjaerbaek N, Søby KK, Hansen HO, Ebert B, Bøgesø KP, Krogsgaard-Larsen P.. (1997) Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships., 40 (18): [PMID:9288165 ] [10.1021/jm970253b ] 2. Vogensen SB, Clausen RP, Greenwood JR, Johansen TN, Pickering DS, Nielsen B, Ebert B, Krogsgaard-Larsen P.. (2005) Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues., 48 (9): [PMID:15857151 ] [10.1021/jm050014l ] 3. Sainas S, Temperini P, Farnsworth JC, Yi F, Møllerud S, Jensen AA, Nielsen B, Passoni A, Kastrup JS, Hansen KB, Boschi D, Pickering DS, Clausen RP, Lolli ML.. (2019) Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands., 62 (9): [PMID:30943028 ] [10.1021/acs.jmedchem.8b01986 ]